References
A. Stoll and A. Hofmann,Helv. Chim. Acta,26(IV), 2070–2081 (1943).
Z. Rehacek and P. Sajdl,Ergot Alkaloids Chemistry, Biological Effects, Biotechnology, J. Trojanek (ed.), CSAV, Prague (1990).
K. Mayer and E. Eich,Pharmazie,39(8), 537–538 (1984).
V. I. Sheichenko,Khim. Prirodn. Soedin., No. 3, 399–402 (1979).
V. I. Sheichenko, A. V. Gaevskii, and O. N. Tolkachev,Khim.-Farm. Zh.,16(5), 618–620 (1982).
V. A. Bykov, E. N. Zvonkova, A. G. Dubichev, et al., RF Patent No. 2078084 (11/10/94).
K. S. Rybalko, T. E. Monakhova, O. A. Konovalova, et al., RF Patent No. 2063968 (7/20/96).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 32, No. 10, pp. 55–56, October, 1998.
Rights and permissions
About this article
Cite this article
Zvonkova, E.N., Sheichenko, V.I., Lapa, G.B. et al. Solubility of dihydroergocristine mesylate. Pharm Chem J 32, 567–568 (1998). https://doi.org/10.1007/BF02465750
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02465750